Melanotan I wurde als stabilerer, selektiver Agonist des Melanocortin-1-Rezeptors (MC1R) auf Melanozyten, den Zellen, die Melanin produzieren, entwickelt
Presented for research literature review only Salinas-Souza C et al
He has independently organised more than 100 Continuing Medical Education (CME) programmes and authored over 200 medical articles for various medical bulletins and healthcare portals, including Medical Dialogues
No identified receptor
We spoke with Seth Kipnis, M.D., a board-certified general surgeon and Medical Director of Bariatric and Robotic Surgery at Jersey Shore University Medical Center, and Ritu Anand, M.D., a board-certified endocrinologist at the Center for Weight Loss at JFK University Medical Center, to explain how bariatric surgery and GLP-1s work, who theyre best for, and what to expect so you can discuss the next right step with your care team